PtX(TM) Human Anti-SARS-CoV-2 Spike RBD (CR3022) Recombinant Antibody, IgG1, Clone: [CR3022], Plant, Monoclonal
Artikelnummer:
CBX-CBT_A0006
Produktübersicht
Artikelname:
PtX(TM) Human Anti-SARS-CoV-2 Spike RBD (CR3022) Recombinant Antibody, IgG1, Clone: [CR3022], Plant, Monoclonal
Artikelnummer:
CBX-CBT_A0006
Hersteller Artikelnummer:
CBT_A0006
Alternativnummer:
CBX-CBT_A0006-100,CBX-CBT_A0006-20
Hersteller:
Cape Biologix Technologies
Wirt:
Plant
Kategorie:
Antikörper
Applikation:
ELISA, WB
Spezies Reaktivität:
Human
Immunogen:
SARS-CoV-2 Spike protein (RBD of S1 subunit)
Alternative Synonym:
Anti-SARS-CoV-2 Receptor Binding Domain Antibody, Anti-RBD, Anti-RBD Antibody, CBT_A0005, Spike RBD, RBD Antibody, RBD Full Form, Receptor Binding Domain
Produktbeschreibung
Recombinant human monoclonal antibody against the Receptor Binding Domain of SARS-CoV-2 Spike protein (subunit 1). This product is produced in Nicotiana benthamiana plants for use in Western blot and ELISA applications.
Produkteigenschaften
Klonalität:
Monoclonal
Konzentration:
1.0 mg/ml
Klon-Bezeichnung:
[CR3022]
Molekulargewicht:
150 kDa +
Isotyp:
IgG1
Tag:
Human IgG1 Fc (chimeric fusion)
UniProt:
P59594
Puffer:
0.1 M Phosphate Buffered Saline (PBS), pH = 7.4
Quelle:
Human
Expression System:
N. Benthamiana
Reinheit:
99.30 % as determined by Mass Spectrometry.
Formulierung:
Liquid
Target-Kategorie:
SARS-CoV-2 Spike protein (RBD of S1 subunit)
Antibody Type:
Recombinant Antibody
Anwendungsbeschreibung
Application Verdünnung:
Optimal dilutions/concentrations should be determined by the user.
Anwendungsbeschreibung:
Optimal dilutions/concentrations should be determined by the user.
